The Pennant Group, Inc. (PNTG) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $31.31 (-0.03%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 7, 2026 | Stephen Baxter | Wells Fargo | $38.00 | +21.4% |
| Oct 23, 2024 | Frank Morgan | RBC Capital | $38.00 | +21.4% |
| Aug 15, 2024 | David MacDonald | Truist Financial | $34.00 | +8.6% |
| Aug 8, 2024 | Scott Fidel | Stephens | $32.00 | +2.2% |
| May 15, 2024 | David MacDonald | Truist Financial | $25.00 | -20.2% |
| May 9, 2024 | Frank Morgan | RBC Capital | $26.00 | -17.0% |
| Jan 5, 2024 | Scott Fidel | Stephens | $18.00 | -42.5% |
| Jul 26, 2022 | David MacDonald | Truist Financial | $12.00 | -61.7% |
Top Analysts Covering PNTG
PNTG vs Sector & Market
| Metric | PNTG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 6 | 8 | 18 |
| Target Upside | +24.6% | +1150.2% | +14.9% |
| P/E Ratio | 37.72 | 6.83 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $285M | $286M | $287M | 4 |
| 2026-09-30 | $288M | $291M | $295M | 2 |
| 2026-12-31 | $299M | $302M | $306M | 3 |
| 2027-03-31 | $298M | $301M | $305M | 3 |
| 2027-06-30 | $301M | $304M | $308M | 2 |
| 2027-09-30 | $305M | $308M | $312M | 2 |
| 2027-12-31 | $316M | $319M | $324M | 3 |
| 2028-12-31 | $1.27B | $1.29B | $1.31B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.32 | $0.32 | $0.33 | 3 |
| 2026-09-30 | $0.34 | $0.34 | $0.35 | 1 |
| 2026-12-31 | $0.35 | $0.36 | $0.36 | 1 |
| 2027-03-31 | $0.35 | $0.36 | $0.36 | 1 |
| 2027-06-30 | $0.38 | $0.39 | $0.39 | 1 |
| 2027-09-30 | $0.39 | $0.40 | $0.40 | 1 |
| 2027-12-31 | $0.41 | $0.42 | $0.43 | 1 |
| 2028-12-31 | $1.91 | $1.92 | $1.92 | 2 |
Frequently Asked Questions
What is the analyst consensus for PNTG?
The consensus among 6 analysts covering The Pennant Group, Inc. (PNTG) is Buy with an average price target of $39.00.
What is the highest price target for PNTG?
The highest price target for PNTG is $38.00, set by Stephen Baxter at Wells Fargo on 2026-01-07.
What is the lowest price target for PNTG?
The lowest price target for PNTG is $12.00, set by David MacDonald at Truist Financial on 2022-07-26.
How many analysts cover PNTG?
6 analysts have issued ratings for The Pennant Group, Inc. in the past 12 months.
Is PNTG a buy or sell right now?
Based on 6 analyst ratings, PNTG has a consensus rating of Buy (2.00/5) with a +24.6% upside to the consensus target of $39.00.
What are the earnings estimates for PNTG?
Analysts estimate PNTG will report EPS of $0.32 for the period ending 2026-06-30, with revenue estimated at $286M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.